News
A proteomics-driven 24-protein classifier improves the differentiation of thyroid adenoma and carcinoma, retrospectively and ...
4h
Sportschosun on MSNHelicobacter infection 2 to 3 times more likely to have stomach cancer...It's the second most common...According to the 2022 national cancer registration statistics, the number of gastric cancer patients was 356,507, accounting ...
Carnegie Mellon University researchers are using personalized models to decode how cancer behaves in individual ...
Clinicians have become reliant on fine-needle aspiration (FNA) cytology in the diagnosis of thyroid nodules. We encountered several patients who had thyroid cancer at operation despite having had ...
Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...
1d
News-Medical.Net on MSNAvelumab and cetuximab combination shows promise in phase II skin cancer trialA phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...
Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...
1d
Medpage Today on MSNAdd-On Nivolumab Extends DFS in Locally Advanced Head and Neck CancerCHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in ...
Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...
MUMBAI, India and PRINCETON, N.J., May 30, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results